Michael Watson has been awarded the American College of Medical Genetics and ACMG Foundation Presidents' Award. Watson is the first recipient of the new award for his work on integrating genetics into medical practice.
Watson was a founder of the ACMG and he co-chaired the National Institutes of Health's ELSI Task Force on Genetics Testing from 1995 until 1997. Currently, he is the director of the National Coordinating Center for Regional Genetics and Newborn Screening. He has been the executive director of the ACMG for the past 10 years and is an adjunct professor of pediatrics at Washington University in St. Louis where he was director of clinical and molecular cytogenetics from 1986 until 2000. He is certified by the American Board of Medical Genetics in clinical cytogenetics and medical genetics.
Watson holds a BS from American University and an MS in medical genetics and PhD in physiology and biophysics from the University of Alabama at Birmingham. He completed his postdoctoral fellowship in the Medical Genetics Training Program
at Yale University School of Medicine.
Gary Augusta is now chief operating officer and a board member at Medomics. Augusta is currently the president of SpaGus Ventures, and the company disclosed his appointment as part of SpaGus' recent investment (see story, same issue).
Augusta has more than 20 years experience in equity investing and strategy and operations management, including as the board director and chief financial advisor at Mediatronics, board advisor at Evantix, and president and CEO of Octane.